Trial intelligence / Profile preview

POMEVAR: Preoperative Methylprednisolone in Endovascular Aortic Repair

2009-013441-28Phase 4Completed

Sponsor
Rigshospitalet
Start
Jul 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of methylprednisolone in abdominal aortic aneurysm (AAA), sponsored by Rigshospitalet. Primary endpoint: Post-implantation syndrome measured by SIRS criteria within first 5 days. Started Jul 2009; status: completed.

02

Drugs

methylprednisolone
03

Conditions

abdominal aortic aneurysm (AAA)

Beyond the preview

Go deeper on 2009-013441-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013441-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call